Ameriprise
ALPN

Ameriprise’s Alpine Immune Sciences Inc ALPN Stock Holding History

Ameriprise’s Portfolio ALPN Stock Details ALPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-15,629
Closed -$811K – 3945
2015
Q3 		$811K Hold
15,629
– – ﹤0.01% 3067
2015
Q2 		$947K Buy
+15,629
New +$931K ﹤0.01% 3149

Other funds holding ALPN

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
TM
Tiger Management New York $22.8M AUM 0.71% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

Ameriprise's ALPN Position: Q4 2015 in Review

Ameriprise sold out of Alpine Immune Sciences Inc (ALPN) in Q4 2015, closing a stake of 15,629 shares — an estimated $811K sold.

Ameriprise first reported a position in ALPN in Q2 2015 and held it in 2 quarters. The position peaked at $947K in Q2 2015. 59 funds tracked by Wall St. Rank hold ALPN as of Q4 2015.

  • Ameriprise reported no remaining Alpine Immune Sciences Inc position as of Q4 2015 after selling out during the quarter.
  • Ameriprise sold 15,629 Alpine Immune Sciences Inc shares in Q4 2015, an estimated $811K.
  • Ameriprise first reported a position in Alpine Immune Sciences Inc in Q2 2015 and held it in 2 quarters.
  • Ameriprise's Alpine Immune Sciences Inc position peaked at $947K in Q2 2015.
  • 59 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q4 2015.

Based on Ameriprise's 13F filing for Q4 2015, filed 11 Feb 2016.